1. Introduction {#sec1}
===============

Angiomyolipomas (AMLs) represent 0.3% of all renal tumors. The sex ratio is 4 men for 11 women. Most of the time, AMLs are sporadic but in 20% of patients AMLs are associated with Tuberous Sclerosis Complex. Thus they are classically multiple, bilateral, and growing \[[@B1]\]. They may become symptomatic and may require active management which has to be as conservative as possible. Many cases of inferior vena cava thrombus associated with AML have been reported \[[@B2]--[@B43]\]. We report a new clinical case of AML with inferior vena cava thrombus in a TSC patient that raises the question of the best surgical approach regarding the necessity of preserving renal function.

2. Materials and Methods {#sec2}
========================

2.1. Observation {#sec2.1}
----------------

A 74-year-old woman with tuberous sclerosis and multiple bilateral AML who had undergone partial polar superior nephrectomy for a renal cell carcinoma in 1990 came after 7 years of surveillance with the evidence of an inferior vena cava thrombus developed from the right renal vein ([Figure 1](#fig1){ref-type="fig"}).

Computerized tomography showed multiple renal tumors with spontaneous density inferior to---20 Hounsfield Units (HU) without contrast enhancement. One of these typical AML that was already present in the previous studies was in contact with a homogenous tumor thrombus, well-circumscribed, with the same fatty density and was extended in the inferior vena cava from the right renal vein, below the hepatic veins ([Figure 2](#fig2){ref-type="fig"}). Serum creatinine was 63 *μ*mol/L.

Partial nephrectomy without arterial clamping, lymphadenectomy, or adrenalectomy with thrombectomy was performed. The thrombus was free from the wall of the inferior vena cava and without fibrin clot. The postoperative period revealed to be uneventful. Serum creatinine was 98 *μ*mol/L, on postoperative day 7 when patient was discharged.

Pathologic examination showed a 7-centimeter yellowish tumor, extended with a thrombus presenting the same aspect. It confirmed the diagnosis of AML given by the association of mature adipose tissue, thick-walled blood vessels, and smooth muscle cells. There was no epithelioid contingency.

Clinical and radiological surveillance after 11 years showed no signs of recurrence or metastasis. The renal vein and inferior vena cava were permeable and the renal function was preserved with 78 *μ*mol/L serum creatinine.

2.2. Literature Review {#sec2.2}
----------------------

A MEDLINE review was performed in order to identify all articles entirely published in English and evaluate inferior vena cava extension of AMLs.

All data are presented in [Table 1](#tab1){ref-type="table"}.

3. Discussion {#sec3}
=============

Venous extension of an AML is rare. We have identified 44 cases of inferior vena cava involvement in the literature including this one.

Medium age was 46.6 years (range 16--75 years). It has a clear female predominance, representing 81.9% of patients. It is concordant to what is observed for common AML \[[@B1]\].

AMLs were bilateral in 31.9% of patients but were associated with TSC only in 11.4% of them.

Surprisingly, we found one case, reported by Camúñez et al. \[[@B5]\] with AML and IVC thrombus without right renal vein involvement. The patient had TSC and bilateral AML and did not undergo surgery. A similar case was reported by Ackali et al.; they described a right renal vein thrombus which extended in the IVC without any tumor of the right kidney on ultrasound examination, computer assisted tomography (CT), and even magnetic resonance imaging (MRI) \[[@B27]\]. They concluded that tumor might have originated from the kidney and then extended to the right renal vein and IVC.

Patients were symptomatic in 67.4% of cases; all were experiencing pain. Gross hematuria was present in 9.3% of patients. Other symptoms were nausea and/or vomiting in 9.1% and fever in 6.8%. Five patients (11.4%) presented a Wunderlich syndrome with acute flank pain and drop of blood pressure or hemoglobin with consistent diagnosis of retroperitoneal hemorrhage due to the rupture of the tumor. TSC was present only in one case of retroperitoneal hemorrhage.

We found that the level thrombus reached the diaphragm in 9 patients (20.5%) and got to the right atrium in 6 patients (13.6%).

In this review, almost all tumors were larger than 4 cm with a mean size of 86.1 mm. Only 2 patients presented a small AML with vena cava thrombus; they had TSC. It has been reported that, in TSC, AMLs are more often symptomatic and have a more aggressive growth pattern \[[@B44]\].

As it has been previously reported, there is a large majority of right sided AML with inferior vena cava thrombus (88.6% versus 11.4%). There is no clear explanation for it. According to Islam et al., when thrombus is limited to the renal vein there is no difference between left or right side \[[@B25]\]. In fact, we have to admit that, before extending into the inferior vena cava, the tumor thrombus was in the renal vein and therefore, predominantly, in the right one.

We also highlight the special case of AML with epithelioid cells which are now recognized as an individual tumor, different from classical AML \[[@B45], [@B46]\]. In this review, recurrence or metastasis was only seen in patients with epithelioid contingency (2 patients, 8.7%). Metastatic localization was the lungs for one and liver and peritoneum for the other. It appears that the size of the tumor is significantly bigger in AML with epithelioid contingency versus classical AML with mean size, respectively, of 127.1 mm versus 82.6 mm (*P* = 0.037, *t*-test).

As reported by Park et al., all reported cases of metastasis of AML in literature were associated with the epithelioid form, expressing the melanocytic marker HMB-45 \[[@B28]\]. The only 2 documented patients with recurrence or metastasis were also epithelioid AML, in our review (HMB-45 positive).

This epithelioid form of AML, characterized by a minor amount of adipose tissues on imaging can mimic the appearance of a clear cell carcinoma \[[@B47]\]. It is reported to quickly evolve towards a metastatic situation with a lethal outcome because of its poor sensitivity to chemotherapy and targeted therapies \[[@B48]\]. Therefore it should be treated aggressively.

There are also malignant tumors presenting with evidence of fat on imaging. Hélénon et al. reported several fat-containing renal cell carcinomas \[[@B49]\]. They were suggesting that diagnosis of AML should be reconsidered in presence of calcification, a large infiltrating or necrotic tumor with association of nonfatty lymph nodes or venous invasion. This review suggests that fat-containing tumors associated with venous fatty thrombus were not malignant tumors at risk of recurrence or metastasis.

In addition, classical AML can be wrongly perceived as clear cell carcinoma in case of recent hemorrhage or spindle cell predominance due to the almost undetectable fat component on imaging \[[@B50]\]. Those cases may benefit from fine-needle biopsy to rule out whether or not the conserving or radical approach should be taken.

Only symptomatic or larger-than-4-centimeter conventional AML should be considered for intervention. Many studies have correlated the risk of hemorrhage/symptomatic presentation with the size of the tumor \[[@B51], [@B52]\]. In this review, mean tumor size was 86.1 mm. Only several patients had medical history of AML and 11.4% of patients were known to have TSC. Those patients would have benefitted from surgical treatment.

A nephron sparing approach by either selective embolization or open or laparoscopic/robotic partial nephrectomy is recommended when an intervention is required \[[@B53]--[@B56]\].

In case of associated venous thrombus, the risk of expansion and cardiopulmonary embolism requires a surgical treatment. Case reported by Shinohara et al. presented with congestive heart failure with a thrombus extended to the right atrium \[[@B57]\].

In case of radical surgery, the prognosis is satisfying. 91.3% of patients remained free from recurrence or metastasis at a median follow-up of 12 months (mean 16.8 months).

Although the presence of a venous thrombus suggests the malignant nature of the primary tumor, conservative surgery is possible. Cases of nephron sparing surgery for T3a or T3b renal cell carcinoma, whether for imperative indications (solitary kidney or renal failure) or intraoperative discovery of the thrombus, showed outcomes that seem acceptable compared to nonconserving surgery \[[@B58]--[@B60]\].

4. Conclusion {#sec4}
=============

Nephron sparing surgery for AML with inferior vena cava extension in tuberous sclerosis is possible depending on the necessity of renal function preservation. It may be proposed as standard surgery for sporadic AML even with inferior vena cava thrombus.
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![Sonography of the IVC thrombus originated from the right renal vein.](CRIU2014-285613.001){#fig1}

![Axial contrast enhanced abdominal CT showing an IVC and renal thrombus with attenuation value---70 HU.](CRIU2014-285613.002){#fig2}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  References                                     Age   Gender   TSC   Symptoms            Localization                    Size (mm)   Thrombus   PE    Fat on imaging   Management                                        LND   Epithelioid form   AE           Rec          Follow-up (months)
  ---------------------------------------------- ----- -------- ----- ------------------- ------------------------------- ----------- ---------- ----- ---------------- ------------------------------------------------- ----- ------------------ ------------ ------------ --------------------
  1982 Kutcher et al. \[[@B2]\]                  16    f        no    p                   Solitary R, upper pole          large       IVC        no    yes              RN, thrombectomy, thoraco-abdominal               no    no                 no           nc           nc

  1985 Brantley et al. \[[@B3]\]                 45    f        no    W: p-N/V-H          Solitary R, upper pole, sinus   90          IVC        no    yes              RN, thrombectomy                                  no    no                 no           no           12

  1986 Rothenberg et al. \[[@B4]\]               62    f        no    p-IVD               Solitary L, upper pole, sinus   45          RA         nc    yes              RN, thrombectomy, middline incision, sternotomy   nc    no                 no           no           36

  1987 Camunez et al. \[[@B5]\]                  22    f        yes   W: p-H              Multiple R                      small       IVC        no    yes              Follow-up                                         no    nc                 no           no           24

  1988 Arenson et al. \[[@B6]\]                  22    f        no    p                   Multiple R, meRian, sinus       85          IVC        no    yes              RN, thrombectomy                                  pos   yes                no           nc           nc

  1992 Umeyama et al. \[[@B7]\]                  75    f        no    p-H                 Solitary R, meRian              160         IVC-B      no    yes              NSS and RN, thrombectomy, bi subcostal            no    no                 no           no           4

  1993 Reiff and Dow \[[@B8]\]                   58    f        no    p-Fever             Solitary R, upper pole, sinus   120         IVC        no    yes              RN, thrombectomy, upper transverse, sternotomy    no    no                 no           no           6

  1993 Honda et al. \[[@B9]\]                    58    f        no    no                  Solitary R, upper pole, sinus   small       IVC        no    yes              RN, thrombectomy                                  no    no                 no           nc           nc

  1994 Morris et al. \[[@B10]\]                  58    f        no    p-fever             Solitary R, upper pole          large       IVC        no    yes              RN, thrombectomy, midline, sternotomy             no    nc                 no           nc           nc

  1994 Moulin et al. \[[@B11]\]                  36    f        yes   p                   Multiple R, upper pole, sinus   large       IVC        no    yes              RN, thrombectomy                                  nc    no                 no           nc           nc

  1995 Leder \[[@B12]\]                          30    f        no    p                   Solitary R median               large       IVC        no    yes              RN, thrombectomy                                  nc    nc                 nc           nc           nc

  1995 Hibi et al. \[[@B13]\]                    31    f        no    p-N                 Solitary R, lower pole          90          IVC        no    yes              RN, thrombectomy                                  neg   no                 no           nc           nc

  1995 Baert et al. \[[@B14]\]                   53    f        no    no                  Solitary R, upper pole          65          IVC        no    yes              RN and thrombectomy, sub costal                   no    no                 no           nc           nc

  1996 Cittadini et al. \[[@B15]\]               65    f        no    no                  Multiple L, sinus               60          IVC        no    yes              Follow-up                                         no    no                 no           nc           12

                                                 67    h        no    W: p-H              Multiple R, meRian, sinus       60          IVC        no    yes              RN, thrombectomy                                  no    no                 no           nc           nc

  1997 Rubio-\                                   64    h        no    no                  Solitary R, meRian              65          IVC        no    yes              RN, thrombectomy, thoraco abdominal               no    nc                 no           nc           nc
  Briones et al. \[[@B16]\]                                                                                                                                                                                                                                                  

  1997 Bernstein et al. \[[@B17]\]               45    h        no    no                  Solitary R, upper pole, sinus   55          IVC        no    yes              RN, thrombectomy, thoraco abdominal               no    no                 no           no           16

  1998 Gotoh et al. \[[@B18]\]                   52    f        no    p                   Solitary R                      35          IVC        no    yes              RN, thrombectomy                                  no    no                 no           no           10

  1999 Christiano et al. \[[@B19]\]              42    h        no    p-loose of weight   Solitary R, lower pole          205         IVC        no    no               RN, thrombectomy                                  pos   yes                no           Meta         15

  1999 Ito et al. \[[@B20]\]                     40    f        no    W: p                Multiple R                      large       IVC        no    yes              RN, thrombectomy                                  no    no                 no           no           36

  2001 Davydov et al. \[[@B21]\]                 46    f        no    p                   Solitary R, upper pole          60          RA         no    yes              RN, thrombectomy, middline                        no    no                 PE           nc           nc

  2002 Wilson et al. \[[@B22]\]                  69    f        no    no                  Solitary R, upper pole, sinus   100         IVC        no    yes              RN, thrombectomy, thoraco abdominal               neg   no                 no           nc           nc

  2003 Schips et al. \[[@B23]\]                  61    f        no    p                   Solitary L, upper pole          100         IVC        no    yes              RN, thrombectomy                                  no    no                 no           no           36

  2003 Gam$\acute{\text{e}}$ et al. \[[@B24]\]   56    f        no    p                   Solitary R, sinus               45          IVC        no    yes              RN, thrombectomy                                  no    no                 no           no           12

  2004 Islam et al. \[[@B25]\]                   40    f        no    no                  Solitary R, Riffuse             110         IVC        no    yes              RN, thrombectomy                                  nc    no                 nc           nc           nc

  2006 Haritharan et al. \[[@B26]\]              48    f        no    p-Fever and N/V     Solitary R                      150         IVC        no    yes              RN, thrombectomy, bi sub costal, sternotomy       no    no                 Hemorrhage   nc           nc

  2006 Akcali et al. \[[@B27]\]                  55    f        no    p                   Solitary R, no renal tumor      0           RA         no    yes              Thombectomy only                                  no    no                 no           nc           nc

  2007 Park et al. \[[@B28]\]                    69    h        no    nc                  Solitary R, Riffuse             130         IVC        no    yes              RN, thrombectomy                                  nc    yes                no           Rec + Meta   12

  2008 Schade et al. \[[@B29]\]                  42    f        yes   p                   Multiple R, upper pole, sinus   90          IVC        no    yes              RN, thrombectomy, thoraco abdominal               no    no                 no           no           22

  2008 Ban et al. \[[@B30]\]                     70    f        no    no                  Solitary R, Riffuse             140         IVC        yes   yes              RN, thrombectomy                                  no    no                 no           no           18

  2008 Moudouni et al. \[[@B31]\]                31    f        no    p                   Multiple L, diffuse             100         IVC        no    yes              RN, thrombectomy, lombotomy                       pos   yes                no           Rec          12

  2009 Sandstrom et al. \[[@B43]\]               31    h        no    p-Chest pain        Solitary L, upper pole, sinus   60          IVC        yes   yes              RN, thrombectomy                                  no    no                 nc           nc           nc

  2009 Christian and Moon \[[@B32]\]             32    h        no    p                   Solitary R, sinus               140         IVC        no    yes              RN, thrombectomy, sub costal                      no    no                 no           no           2

  2009 Durand et al. \[[@B33]\]                  57    f        no    no                  Multiple R, upper pole, sinus   45          IVC        no    yes              RN, thrombectomy                                  no    no                 no           nc           nc

  2010 Tan et al. \[[@B34]\]                     44    h        no    no                  Solitary R, sinus               100         IVC        no    yes              RN, thrombectomy, bi sub costal                   no    no                 PE           no           12

  2011 Govednik-Horny and Atkins \[[@B35]\]      30    f        yes   no                  Multiple R, lower pole          80          IVC        no    yes              Embolization, RN, thrombectomy, lombotomy         no    yes                no           nc           nc

  2011 Lopater et al. \[[@B36]\]                 34    f        no    no                  Multiple R                      30          IVC        no    yes              Thrombectomy first then NSS, sub costal           no    no                 no           nc           nc

  2011 Mittal et al. \[[@B37]\]                  46    f        no    p                   Solitary R, upper pole, sinus   70          IVC        no    yes              RN, thrombectomy, middline                        no    no                 no           no           3

  2013 Grant et al. \[[@B38]\]                   22    f        no    p                   Solitary R, Riffuse             90          IVC        no    no               RN, thrombectomy                                  no    yes                PE           nc           nc

  2013 Li et al. \[[@B39]\]                      52    f        no    p                   Solitary R, lower pole          125         RA         yes   yes              RN, thrombectomy                                  no    yes                no           no           6

  2013 Li et al. \[[@B40]\]                      43    f        no    W: p                Solitary R, upper pole          55          IVC        no    yes              Embolization, RN, thrombectomy                    no    no                 no           no           3

  2013 Fernandez-Pello et al. \[[@B41]\]         22    f        no    no                  Solitary R, sinus               80          IVC        no    yes              RN, thrombectomy, laparoscopic                    no    no                 no           no           3

  2013 Nouira et al. \[[@B42]\]                  34    f        no    p                   Multiple R, Riffuse             80          RA         no    yes              RN, thrombectomy, bi sub costal, sternotomy       no    nc                 DC sepsis    dc           dc

  2013 A. Riviere                                74    f        yes   no                  Multiple R, meRian              70          IVC        no    yes              NSS, thrombectomy, lombotomy                      no    no                 no           no           84
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

R: right; N*∖*V: Nausea*∖*Vomitting; IVC: Inferior Vena Cava; NSS: Nephron Sparing Surgery; nc: not communicated; Meta: Metastasis; L: left; W: Wunderlich syndrome; RA: Right Atrium; PE: Pulmonary Embolism; Pos: Positive; H: gross hematuria; p: pain RN: Radical Nephrectomy; DC: Deseaded; Rec: Recurrence; Neg: Negative; LND: Lymph node Dissection.
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